Release Date: 07/10/19 12:18 Summary: Extension of voluntary suspension Price Sensitive: No Download Document 275.69KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%